Home Exercise for Individuals With Neurodegenerative Disease
NCT05443906
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The primary goal of this study is to address the need for targeted therapeutic interventions for impairments that impact walking in related neurodegenerative diseases.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Neurodegenerative Diseases
- Leukodystrophy
- Ataxia
- LBSL
- Leukoencephalopathy With Brain Stem and Spinal Cord Involvement and High Lactate Syndrome (Disorder)
- Leukoencephalopathy With Brainstem and Spinal Cord Involvement and Lactate Elevation
- Cerebellar Ataxia
- Adrenomyeloneuropathy
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 5 to 75 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
- Last updated on ClinicalTrials.gov
- September 16, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Maryland · 1
- Kennedy Krieger Institute · Baltimore, MD
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.